The 5 HLA-A*02:01 and HA-1H positive patients with AML who were treated with the HA-1H TCR-transduced CMV or EBV-specific T-cells 8 and 14 weeks after T-cell depleted alloSCT did not experience infusion related toxicity, and no significant development or worsening of GVHD was observed. Here, HLA-A is linked to acute myeloid leukemia.